Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 1/20 | 0.38 |
| ▸ | NNMT | P40261 | 4/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 2/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.31 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8429670 | 0.80 | TRPV1 (0.36) | AAK1SMN1; SMN2L3MBTL1 | |
| SCHEMBL8431440 | 0.72 | NNMT (0.50) | NNMTSMN1; SMN2KDM4EL3MBTL1PARP10 | |
| SCHEMBL6663166 | 0.68 | AAK1 (0.46) | AAK1NNMTSMN1; SMN2KDM4EL3MBTL1 | |
| SCHEMBL22182995 | 0.66 | NNMT (0.52) | NNMTSMN1; SMN2KDM4EL3MBTL1MAPK1 | |
| SCHEMBL25347292 | 0.64 | PARP10 (0.43) | AAK1L3MBTL1PARP10EPHX2 | |
| SCHEMBL978974 | 0.64 | NNMT (0.63) | NNMTSMN1; SMN2KDM4EL3MBTL1MAPK1 | |
| SCHEMBL7081537 | 0.63 | NNMT (0.57) | NNMTSMN1; SMN2KDM4EL3MBTL1MAPK1 | |
| SCHEMBL840090 | 0.63 | NNMT (0.45) | NNMTSMN1; SMN2KDM4EL3MBTL1PARP10 | |
| SCHEMBL14829450 | 0.63 | AOC3 (0.45) | AAK1SMN1; SMN2PARP10EPHX2 | |
| Hydrochloric Acid SCHEMBL6485765 | 0.63 | NNMT (0.61) | NNMTSMN1; SMN2KDM4EL3MBTL1MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5861423-A | SIDE EFFECT REDUCTION; ADMINISTERING TO TREAT CENTRAL NERVOUS SYSTEM DISORDERS; ALZHEIMER*S AND PARKINSON*S DISEASE; ATTENTION DEFICIT DISORDER, SCHIZOPHRENIA | TARGACEPT, INC., A CORPORATION OF DELAWARE | 1999-01-19 | — | — | US | disclosed |
| US-5811442-A | ADMINISTERING ARYL SUBSTITUTED OLEFINIC AMINE COMPOUND IN AN AMOUNT SUFFICIENT TO SELECTIVELY BIND TO AND AFFECT NICOTINIC CHOLINERGIC RECEPTOR SUBTYPES CONTAINING BETA2 SUBUNITS | TARGACEPT, INC. | 1998-09-22 | — | — | US | disclosed |